1. Efficacy, safety and prognostic factors of camrelizumab plus carboplatin and pemetrexed chemotherapy in advanced lung adenocarcinoma patients. (9th April 2022) Authors: Lv, Jialing; Zhang, Wen; Deng, Ruoyu; Chen, Yanqiong; Liu, Meiyan; Zhang, Zhijun; Wang, Qing; He, Yongmei; Liu, Yaling; Wang, Fengting; Lv, Zengbo; Zhou, Huahua; Li, Chongxin; Zhang, Tengfei; Fu, Yanyan; Zhao, Xingqiang; Bao, Qiuping; Miao, Yi; Wang, Lin; Huang, Meifang Journal: Journal of clinical pharmacy and therapeutics Issue: Volume 47:Number 8(2022) Page Start: 1257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗